Location: Princeton, NJ
CIK: 0001388551 · Show all filings
Period: Q4 2023 (← Previous) (Next →)
Filing Date: Feb 14, 2024
Total Value: $18.52M (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| XERS | XERIS BIOPHARMA HOLDINGS INC | 5,641,920 | $13.26M | 71.6% | $2.16 | -14.6% | COM | 98422E103 |
| SVRA | SAVARA INC | 353,441 | $1.661M | 9.0% | $1.66 | +130.3% | COM | 805111101 |
| RZLT | REZOLUTE INC | 1,318,967 | $1.309M | 7.1% | $9.52 | -90.4% | COM NEW | 76200L309 |
| SPY | SPDR S&P 500 ETF TR | 1,322 | $628K | 3.4% | $475.15 | — | TR UNIT | 78462F103 |
| — | MOLECULAR TEMPLATES INC | 136,866 | $511K | 2.8% | $6.32 | — | COM NEW | 608550208 |
| BRK/B | BERKSHIRE HATHAWAY INC DEL | 1,035 | $369K | 2.0% | $350.99 | 0.0% | CL B NEW | 084670702 |
| APGE | APOGEE THERAPEUTICS INC | 7,353 | $205K | 1.1% | $22.03 | -9.0% | COM | 03770N101 |
| ABVX | ABIVAX SA | 16,743 | $179K | 1.0% | $10.70 | — | SPONSORED ADS | 00370M103 |
| LXEO | LEXEO THERAPEUTICS INC | 10,319 | $138K | 0.7% | $12.42 | 0.0% | COM | 52886X107 |
| — | HARPOON THERAPEUTICS INC | 13,176 | $129K | 0.7% | $9.81 | — | COM NEW | 41358P205 |
| CMPX | COMPASS THERAPEUTICS INC | 43,465 | $67,806 | 0.4% | $3.23 | -46.5% | COM | 20454B104 |
| — | ALLAKOS INC | 24,710 | $67,457 | 0.4% | $3.36 | — | COM | 01671P100 |